SCHEDULE 13D/AAccepted Mar 7, 6:15 PM ET
BridgeBio Pharma, Inc. SCHEDULE 13D/A
Accepted (ET)
6:15 PM
Mar 7, 2025
Filed
Mar 7, 2025
Documents
1
Size
15.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.